Dynavax Technologies Corp. | Key People and Executives
Arnold Lewis Oronsky
Chairman
Eddie J. Gray
Chief Executive Officer & Director
Peggy V. Phillips
Independent Director
Laura A. Brege
Independent Director
Francis R. Cano
Independent Director
Natale S. Ricciardi
Independent Director
Dennis A. Carson
Independent Director
Daniel L. Kisner
Independent Director
Eddie J. Gray
Chief Executive Officer & Director
David F. Novack
Senior Vice President-Operations & Quality
Michael S. Ostrach
Chief Financial & Business Officer, Senior VP
Robert Janssen
Chief Medical Officer & SVP-Regulatory Affairs
Robert L. Coffman
Chief Scientific Officer & Senior Vice President
Steven N. Gersten
Secretary, Chief Ethics & Compliance Officer, VP
David Louis Johnson
Chief Accounting Officer & Vice President
David Burke
Director-IR & Corporate Communications
Cecilia Vitug
Vice President-Human Resources
Arnold Lewis Oronsky
Chairman
Peggy V. Phillips
Independent Director
Laura A. Brege
Independent Director
Francis R. Cano
Independent Director
Natale S. Ricciardi
Independent Director
Dennis A. Carson
Independent Director
Daniel L. Kisner
Independent Director
| Address |
2929 Seventh Street
Berkeley California 94710
United States
|
|
Employees
|
- |
| Website |
http://www.dynavax.com |
| Updated |
07/08/2019 |
| Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. |
